Tesfahun Esubalew, Eshete Demsash, Abebe Zenebe, Hailemeskel Solomon
School of Public Health Asrat Woldeyes Health Science Campus Debre Berhan University Debre Berhan Ethiopia.
School of Nursing and Midwifery Asrat Woldeyes Health Science Campus, Debre Berhan University Debre Berhan Ethiopia.
Health Sci Rep. 2025 Aug 19;8(8):e71178. doi: 10.1002/hsr2.71178. eCollection 2025 Aug.
Pre-invasive cervical lesion typically progresses for a considerable amount of time before developing into cervical cancer (CC). Consequently, early detection and treatment of cervical cancer at the pre-invasive stage may be advantageous to the patients and lessen the burden of morbidity and mortality from the disease. Our country has limited studies on Precancerous Cervical Lesions (PCCL).
To assess the prevalence and associated factors of precancerous cervical lesions among HIV-positive and negative women in Debre Birhan Comprehensive Specialized Hospital, Ethiopia.
An institutional-based comparative cross-sectional study was conducted from July/2021 to June/2023 among 522 women attending cervical cancer screening at Debre Birhan Comprehensive Specialized Hospital. All records during the study period were collected using a structured data extraction checklist. Binary logistic regression analyses were conducted to identify factors associated with pre-cancerous cervical lesions.
The overall prevalence of pre-cancerous cervical lesions was 8% (95% CI: 5.6-10.5. The prevalence of pre-cancerous cervical lesions in HIV-positive was 5.4% (95% CI: 2.8-.1) and in HIV-negative women 10.7% (95% CI: 5.6-8.1). Women with lifetime sexual partner ≥ 2 (AOR = 3.84, 95% CI: 1.06-3.97), who have a history of STI (AOR = 5.66, 95% CI: 1.50-21.41) and women with age ≥ 45 years (AOR = 4.22, 95% CI: 1.21-14.76) were contributing factors of a PCCL for HIV-positive women. In addition, women with a history of Sexually Transmitted Infection (STI) (AOR = 6.51, 95% CI: 2.11-0.09) and who have a lifetime sexual partner ≥ 2 (AOR = 8.4, 95% CI: 2.85-4.79) were statistically significant association with pre-cancerous cervical lesion for HIV-negative women.
The overall prevalence of pre-cancerous cervical lesions was found to be low in this study relative to the national prevalence. However, strengthening routine screening of women for pre-cancerous cervical lesions and behavioural change communication on risk factors is very important.
宫颈浸润前病变通常在发展为宫颈癌(CC)之前会持续相当长一段时间。因此,在浸润前阶段早期发现和治疗宫颈癌可能对患者有利,并减轻该疾病的发病和死亡负担。我国对宫颈上皮内瘤变(PCCL)的研究有限。
评估埃塞俄比亚德布雷伯尔汉综合专科医院艾滋病毒阳性和阴性女性中宫颈上皮内瘤变的患病率及相关因素。
于2021年7月至2023年6月在德布雷伯尔汉综合专科医院对522名接受宫颈癌筛查的女性进行了一项基于机构的比较横断面研究。研究期间的所有记录均使用结构化数据提取清单收集。进行二元逻辑回归分析以确定与宫颈上皮内瘤变相关的因素。
宫颈上皮内瘤变的总体患病率为8%(95%CI:5.6 - 10.5)。艾滋病毒阳性女性中宫颈上皮内瘤变的患病率为5.4%(95%CI:2.8 - 1.1),艾滋病毒阴性女性中为10.7%(95%CI:5.6 - 8.1)。终身性伴侣≥2名的女性(调整后比值比[AOR]=3.84,95%CI:1.06 - 3.97)、有性传播感染病史的女性(AOR = 5.66,95%CI:1.50 - 21.41)以及年龄≥45岁的女性(AOR = 4.22,95%CI:1.21 - 14.76)是艾滋病毒阳性女性发生宫颈上皮内瘤变的影响因素。此外,有性传播感染(STI)病史的女性(AOR = 6.51,95%CI:2.11 - 0.09)和终身性伴侣≥2名的女性(AOR = 8.4,95%CI:2.85 - 4.79)与艾滋病毒阴性女性的宫颈上皮内瘤变存在统计学上的显著关联。
本研究中宫颈上皮内瘤变的总体患病率相对于全国患病率较低。然而,加强对女性宫颈上皮内瘤变的常规筛查以及关于危险因素的行为改变宣传非常重要。